7 Ensemble Capital Johnson & Johnson Trades
Ensemble Capital started to build up the position in Johnson & Johnson in Q1 2013. Since then they sold 8.28k shares. The investor completely sold their stake between Q2 2013 and Q3 2015.
News about Johnson & Johnson and Ensemble Capital
Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript
Johnson & Johnson (NYSE:JNJ ) Q3 2024 Earnings Conference Call October 15, 2024 8:30 AM ET Company Participants Jessica Moore - Vice President, Investor Rela...
Johnson & Johnson urges shareholders to rebuff TRC Capital mini-tender
No summary available.
Capstan Therapeutics Raises $175M in Series B Financing
Capstan Therapeutics, a San Diego, CA-based biotechnology company dedicated to advancing in vivo reprogramming of cells through RNA delivery using targeted l...
David Einhorn¡¯s Greenlight Capital adds Kenvue, ETFs and exits Southwestern Energy
Greenlight Capital picks up a new stake in Kenvue Inc, formerly the consumer healthcare division of Johnson & Johnson.